Turner Syndrome and Beta Thalassemia Major: A Rare Association

Document Type : Case Report

Authors

1 Children Growth Disorder Research Center, Shahid Sadoughi University of Medical Sciences, Yazd, Iran

2 Department of Pediatrics, Shahid Sadoughi Hospital, Shahid Sadoughi University of Medical Sciences, Yazd, Iran

3 Mother and Newborn Health Research Center, Shahid Sadoughi University of Medical Sciences, Yazd, Iran

4 Department of Biology, Faculty of Science, Yazd University, Yazd, Iran

Abstract

Background: Turner syndrome (TS) is the most common genetic disorder affecting only females. The criteria for diagnosis include the complete or partial absence of the second sex (x) chromosome (with or without cell line mosaicism) plus short stature and primary ovarian failure with or without the presence of other phenotypic TS features. The genotype in TS, as tested in peripheral blood, is most commonly 45xo. β-thalassemia major or transfusion-dependent thalassemia refers to severe β-thalassemia that requires early transfusion therapy. The association between Turner syndrome and thalassemia major is rare, which may result from transcription factor gene mutation.
Case Report: We report a girl with thalassemia major who was treated by recurring monthly transfusions since the age of six months. Short stature, triangular face, low set ear, hypertelorism, webbed neck, lordosis and genu valgum were observed in the examination. The patient was diagnosed with Turner syndrome, and her karyotype also was defined as 45xo.
Conclusion: In the case of Turner syndrome and β-thalassemia major association, a mutation in the transcription factor gene is proposed, which can be confirmed by genetic testing.

Keywords


  1. Hu J, Wang Y. The clinical characteristics and risk factors of severe COVID-19. Gerontology 2021; 67(3): 255-66.
  2. Fenderson BA. Developmental and genetic diseases. In: Damjanov I, editor. Pathol secrets. Philadelphia, PA: Mosby; 2009. p. 98-119.
  3. Kliegman RM, Marcdante K, Behrman RE, Jenson HB. Nelson textbook of pediatrics. 21st Philadelphia, PA: Elsevier; 2020. p. 778-8.
  4. Cabrol S. Turner syndrome. Ann Endocrinol (Paris) 2007; 68(1): 2-9.
  5. Clemente EG, Penukonda SK, Doan T, Sullivan B, Kanungo S. Turner syndrome. Endocrines 2022; 3(2): 240-54.
  6. Kliegman RM, Marcdante K, Behrman RE, Jenson HB. Nelson textbook of pediatrics. 21st Philadelphia, PA: Elsevier; 2020. p. 669.
  7. Kliegman RM, Marcdante K, Behrman RE, Jenson HB. Nelson textbook of pediatrics. 21st Philadelphia, PA: Elsevier; 2020. p. 3004.
  8. Thein SL. Genetic insights into the clinical diversity of beta thalassaemia. Br J Haematol 2004; 124(3): 264-74.
  9. Stoicanescu D, Cevei M, Belengeanu V, Stoian S, Belengeanu A. Rare association between two genetic conditions: turner syndrome and beta thalassemia minor. Analele Univ din Oradea Fasc Biol 2009; 2016(2): 138-41.
  10. Sarafoglou K, Hoffmann GF, Roth KS. Pediatric endocrinology and inborn errors of metabolism. 2nd New York, NY: McGraw Hill Medical; 2017. p. 75-6.
  11. Kliegman RM, Marcdante K, Behrman RE, Jenson HB. Nelson textbook of pediatrics. 21st Philadelphia, PA: Elsevier; 2020. p. 3002.
  12. Loscalzo J, Fauci AS, Kasper DL, Hauser S, Longo D, Jameson JL. Harrison’s principles of internal medicine. 21st New York, NY: McGraw-Hill; 2022. p. 785.
Volume 5, Issue 2
December 2022
Pages 99-101
  • Receive Date: 29 December 2022
  • Accept Date: 29 December 2022
  • First Publish Date: 29 December 2022